SMTL ID : 6uwu.1

Crystal Structure of the first bromodomain of human BRD4 in complex with the inhibitor ZL0516

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

5 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 4 residues within 4Å: Chain A: P.101, V.106, L.107, E.110 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:P.101 Water bridges: A:E.110 EDO.2: 6 residues within 4Å: Chain A: P.6, P.45, D.65, G.67, T.68, K.71 1 PLIP interactions: 1 interactions with chain A Water bridges: A:Q.43 EDO.3: 6 residues within 4Å: Chain A: I.59, I.60, K.61, T.62, N.94 Ligands: EDO.5 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:I.59, A:K.61, A:T.62, A:T.62 EDO.4: 2 residues within 4Å: Chain A: D.55, Y.98 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:Y.98 Water bridges: A:D.55, A:D.55 EDO.5: 2 residues within 4Å: Chain A: I.59 Ligands: EDO.3 No protein-ligand interaction detected (PLIP)

1 x QKP: 2-{4-[(2R)-2-hydroxy-3-(4-methylpiperazin-1-yl)propoxy]-3,5-dimethylphenyl}-5,7-dimethoxy-4H-1-benzopyran-4-one(Non-covalent)

QKP.6: 8 residues within 4Å: Chain A: P.41, F.42, V.46, L.51, L.53, Y.56, N.99, I.105 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:P.41, A:V.46, A:L.51, A:L.53, A:L.53, A:L.53, A:I.105, A:I.105, A:I.105 Hydrogen bonds: A:N.99 Water bridges: A:Q.44

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, Z. et al., Discovery of Orally Bioavailable Chromone Derivatives as Potent and Selective BRD4 Inhibitors: Scaffold Hopping, Optimization, and Pharmacological Evaluation. J.Med.Chem. (2020)

Release Date

2020-04-15

Peptides

Bromodomain-containing protein 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Bromodomain-containing protein 4

Related Entries With Identical Sequence